Bonista PF Injection
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Teriparatide (250mcg/ml)
Overview Bonista PF Injection
Parathyroid hormone analog, Terapath PF Injection, treats severe osteoporosis and high fracture risk in men and postmenopausal women. Its mechanism involves stimulating bone growth, thus increasing bone density and reducing spinal fracture likelihood. Administered subcutaneously or by a healthcare provider, Terapath PF Injection requires consistent daily use for optimal efficacy. A typical treatment duration is up to two years; however, complete the prescribed course as directed by your physician. Refrigerate between 2°C and 8°C. Common side effects may include arthralgia, injection site inflammation (pain, swelling, erythema), and leg spasms. Report persistent or bothersome side effects to your doctor. Prior to commencing treatment, disclose any kidney issues, including kidney stones, as hypercalcemia may occur. Pregnant or lactating individuals should seek medical counsel before use. Your doctor may utilize bone densitometry to track treatment progress.
Primary Ingredients of Bonista PF Injection
No information provided. Please provide the text you wish to be rephrased.
Uses of Bonista PF Injection
Brittle bone disease
Major Benefits of Bonista PF Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Bonista PF Injection:
- Joint pain
- Injection site reactions (pain, swelling, redness)
- Nausea
- Leg cramps
How to use Bonista PF Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Bonista PF Injection works:
Bonista PF Injection is a manufactured version of the naturally occurring parathyroid hormone (PTH). Its mechanism of action involves stimulating osteoblast proliferation and activity, leading to enhanced bone density and a reduced fracture risk.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Bonista PF Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Use of Bonista PF Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Bonista PF Injection with breastfeeding are lacking. Seek medical advice from your physician.
DrivingUNSAFE
Administering Bonista PF Injection might reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
For individuals with kidney impairment, Bonista PF Injection requires careful administration and potential dosage modification. Patients with severe kidney disease should avoid using Bonista PF Injection. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Bonista PF Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Bonista PF Injection :
Should you forget a Bonista PF Injection, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bonista PF Injection
Label | Value |
---|---|
Chemical Type | Parathyroid Hormone-Related Peptides |
Developing Habits | No. |
Treatment Category | Endocrine Signals |